FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891487592> ?p ?o ?g. }

• W2891487592 abstract "e20701 Background: Quantifying circulating tumor DNA (ctDNA) is an emerging method to non-invasively assess treatment effect for solid tumors. Despite disease heterogeneity in NSCLC, we set out to identify a broadly applicable ctDNA-based method for disease monitoring. By employing plasma taken during early treatment cycles, we tested whether early response assessed by ctDNA level could predict treatment effect. Methods: Using a 197-gene NGS assay, the AVENIO ctDNA Surveillance Kit (For Research Use Only, not for use in diagnostic procedures), we measured ctDNA levels in post-treatment plasma samples based on variants identified at baseline. We used samples from an observational German Lung Cancer Multi-Marker Study. In a cohort of 83 stage IV lung adenocarcinoma treated with first-line chemo or chemoradiation therapies, we evaluated the association between survival and ctDNA levels in the first available post-treatment plasma sample (median number of days after start of treatment = 23). We used a ctDNA-based monitoring algorithm, and applied it to an independent set of 22 late stage lung squamous cell carcinoma (SCC) that also underwent chemo or chemoradiation therapies to further evaluate the algorithm in different histology subtypes. Results: We divided the 83 adenocarcinoma cohort into training (n = 53) and test (n = 30) sets. We found that subjects with longer progression free survival (PFS) had mean allele fraction (AF) < 1% in the training set. We applied the classifier to our validation set and found that subjects with mean AF < 1% had longer PFS (HR 0.35; 95% CI 0.12 - 0.93; log-rank P = 0.028) and overall survival (OS) (HR 0.29; 95% CI 0.09 - 0.89; log-rank P = 0.021). Using cutoffs identified in adenocarcinoma, we applied the same algorithms to the SCC cohort. Subjects with mean AF < 1% had longer PFS (HR 0.26; 95% CI 0.10 - 0.71; log-rank P = 0.005) and OS (HR 0.12; 95% CI 0.05 - 0.51; log-rank P = 0.001). Conclusions: Even in heterogeneous diseases such as NSCLC, changes in ctDNA levels in response to treatment may prove to be a valuable way of identifying subjects who may not benefit, which is earlier than current standard of care methods like computed tomography (CT) scan. Future prospective studies to confirm these results are warranted." @default.
• W2891487592 created "2018-09-27" @default.
• W2891487592 creator A5006624449 @default.
• W2891487592 creator A5013804417 @default.
• W2891487592 creator A5015189224 @default.
• W2891487592 creator A5024585720 @default.
• W2891487592 creator A5032155554 @default.
• W2891487592 creator A5032786481 @default.
• W2891487592 creator A5037979692 @default.
• W2891487592 creator A5040695029 @default.
• W2891487592 creator A5064807273 @default.
• W2891487592 creator A5072714653 @default.
• W2891487592 creator A5072993047 @default.
• W2891487592 creator A5082143285 @default.
• W2891487592 creator A5083247969 @default.
• W2891487592 creator A5084964726 @default.
• W2891487592 creator A5085505239 @default.
• W2891487592 date "2019-05-20" @default.
• W2891487592 modified "2023-09-26" @default.
• W2891487592 title "Early assessment of therapy response in non-small cell lung cancer (NSCLC) via longitudinal ctDNA analysis." @default.
• W2891487592 doi "https://doi.org/10.1200/jco.2019.37.15_suppl.e20701" @default.
• W2891487592 hasPublicationYear "2019" @default.
• W2891487592 type Work @default.
• W2891487592 sameAs 2891487592 @default.
• W2891487592 citedByCount "0" @default.
• W2891487592 crossrefType "journal-article" @default.
• W2891487592 hasAuthorship W2891487592A5006624449 @default.
• W2891487592 hasAuthorship W2891487592A5013804417 @default.
• W2891487592 hasAuthorship W2891487592A5015189224 @default.
• W2891487592 hasAuthorship W2891487592A5024585720 @default.
• W2891487592 hasAuthorship W2891487592A5032155554 @default.
• W2891487592 hasAuthorship W2891487592A5032786481 @default.
• W2891487592 hasAuthorship W2891487592A5037979692 @default.
• W2891487592 hasAuthorship W2891487592A5040695029 @default.
• W2891487592 hasAuthorship W2891487592A5064807273 @default.
• W2891487592 hasAuthorship W2891487592A5072714653 @default.
• W2891487592 hasAuthorship W2891487592A5072993047 @default.
• W2891487592 hasAuthorship W2891487592A5082143285 @default.
• W2891487592 hasAuthorship W2891487592A5083247969 @default.
• W2891487592 hasAuthorship W2891487592A5084964726 @default.
• W2891487592 hasAuthorship W2891487592A5085505239 @default.
• W2891487592 hasConcept C121608353 @default.
• W2891487592 hasConcept C126322002 @default.
• W2891487592 hasConcept C143998085 @default.
• W2891487592 hasConcept C146357865 @default.
• W2891487592 hasConcept C151730666 @default.
• W2891487592 hasConcept C2776256026 @default.
• W2891487592 hasConcept C2781182431 @default.
• W2891487592 hasConcept C50382708 @default.
• W2891487592 hasConcept C71924100 @default.
• W2891487592 hasConcept C72563966 @default.
• W2891487592 hasConcept C86803240 @default.
• W2891487592 hasConceptScore W2891487592C121608353 @default.
• W2891487592 hasConceptScore W2891487592C126322002 @default.
• W2891487592 hasConceptScore W2891487592C143998085 @default.
• W2891487592 hasConceptScore W2891487592C146357865 @default.
• W2891487592 hasConceptScore W2891487592C151730666 @default.
• W2891487592 hasConceptScore W2891487592C2776256026 @default.
• W2891487592 hasConceptScore W2891487592C2781182431 @default.
• W2891487592 hasConceptScore W2891487592C50382708 @default.
• W2891487592 hasConceptScore W2891487592C71924100 @default.
• W2891487592 hasConceptScore W2891487592C72563966 @default.
• W2891487592 hasConceptScore W2891487592C86803240 @default.
• W2891487592 hasLocation W28914875921 @default.
• W2891487592 hasOpenAccess W2891487592 @default.
• W2891487592 hasPrimaryLocation W28914875921 @default.
• W2891487592 hasRelatedWork W2147367600 @default.
• W2891487592 hasRelatedWork W2388931413 @default.
• W2891487592 hasRelatedWork W2389744545 @default.
• W2891487592 hasRelatedWork W2400217987 @default.
• W2891487592 hasRelatedWork W2403361534 @default.
• W2891487592 hasRelatedWork W2406962104 @default.
• W2891487592 hasRelatedWork W2465910797 @default.
• W2891487592 hasRelatedWork W2801241205 @default.
• W2891487592 hasRelatedWork W3171615116 @default.
• W2891487592 hasRelatedWork W4200188553 @default.
• W2891487592 isParatext "false" @default.
• W2891487592 isRetracted "false" @default.
• W2891487592 magId "2891487592" @default.
• W2891487592 workType "article" @default.